Clarithromycin for Animals

Clarithromycin

Clarithromycin is a semisynthetic macrolide antibacterial with substantial tissue and intracellular distribution. Its major equine application is combination treatment of Rhodococcus equi infection in foals. In small animals, it is used less commonly for selected susceptible infections, including some atypical mycobacterial infections and Helicobacter-associated disease.

Group

Macrolide antibacterial

Mechanism of Action

Clarithromycin binds to the 50S bacterial ribosomal subunit and interferes with translocation and elongation of the nascent peptide chain. Inhibition of protein synthesis generally produces a bacteriostatic effect, with bactericidal activity possible against some highly susceptible organisms. Accumulation in cells and respiratory tissues supports its activity against intracellular pathogens such as Rhodococcus equi and selected mycobacteria.

Dose Rates

Dogs

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection7.5 mg/kgPOEvery 12 h
Bacterial infections2.5–10 mg/kgPOEvery 12 h
Bacterial infections5–10 mg/kgPOEvery 12 h
Canine leproid granuloma combination treatmentReference onlyPOClarithromycin 15–25 mg/kg TOTAL DAILY orally divided every 8–12 hours plus rifampin 10–15 mg/kg orally daily, usually for 4–8 weeks until lesions substantially regress or resolve.

Cats

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection7.5 mg/kgPOEvery 12 h
Feline leprosy combination treatmentReference onlyPOUse two or three agents selected from clarithromycin 62.5 mg per cat every 12 hours, clofazimine 25–50 mg daily or 50 mg every other day, and rifampin 10–15 mg/kg daily. Maintain a diagnosis-specific specialist combination plan.
Nocardia nova combination treatmentReference onlyPOAmoxicillin 20 mg/kg orally every 12 hours with clarithromycin 62.5–125 mg per cat orally every 12 hours and/or doxycycline at least 5 mg/kg every 12 hours. The doxycycline lower-bound statement is not an invented bounded range.
Helicobacter combination treatmentReference onlyPOClarithromycin 7.5 mg/kg, metronidazole 10–15 mg/kg and amoxicillin 20 mg/kg, each orally every 12 hours for 14 days.
Historical mycobacterial combination treatmentReference onlyPOAn older M. bovis protocol combines clarithromycin 5–10 mg/kg every 12 hours, rifampin 10–20 mg/kg daily and enrofloxacin 5–10 mg/kg every 12–24 hours for at least two months, then two drugs for four additional months. This is a zoonotic-disease and combination-management issue, not a routine calculator regimen; feline enrofloxacin exposure also requires separate safety review.

Horses

Use / stageDoseRouteScheduleInstructions
Rhodococcus equi infection7.5 mg/kgPOEvery 12 hFoals only. Often combined with rifampin 10 mg/kg orally every 12 hours.

Pigs

Use / stageDoseRouteScheduleInstructions
Susceptible bacterial infection7.5 mg/kgPOEvery 12 h

Ferrets

Use / stageDoseRouteScheduleInstructions
Helicobacter mustelae treatmentReference onlyPOClarithromycin 12.5 mg/kg orally every 12 hours with ranitidine bismuth citrate 24 mg/kg every 12 hours for 14 days; another report uses eight-hour intervals. Product availability and exact bismuth salt differ from subsalicylate.
Alternative Helicobacter treatmentReference onlyPOClarithromycin 12.5–50 mg/kg every 8–24 hours with omeprazole 0.7 mg/kg orally daily; the route for clarithromycin is not independently assigned in this bullet.

Indications

  • Treatment of Rhodococcus equi pneumonia and associated susceptible infections in foals, generally in combination with rifampin.
  • Combination treatment of selected atypical mycobacterial infections in dogs and cats.
  • Treatment of selected Helicobacter-associated gastric disease in cats or ferrets as part of a combination regimen.
  • Treatment of selected susceptible respiratory, skin or soft-tissue infections in small animals.

Contraindications

  • Use cautiously in adult horses, ruminants, rodents and rabbits because of enteritis risk.
  • Pregnancy requires caution.

Interactions

  • CYP inhibition can increase concentrations of other medicines, including cyclosporine.
  • Rifampin can markedly reduce clarithromycin exposure despite their established combination use.

Adverse effects

  • Nausea
  • Soft stools or diarrhea
  • Severe enteritis in susceptible species

Preparations

PreparationFormStrengthRoute
Clarithromycin 250 mg tabletTablet250 mg / tabletPO
Clarithromycin 500 mg tabletTablet500 mg / tabletPO
Clarithromycin 25 mg/mL oral liquidOral Liquid25 mg / mLPO
Clarithromycin 50 mg/mL oral liquidOral Liquid50 mg / mLPO
Claritek 250 mg tablet
Getz Pharma (Pvt.) Limited
Tablet250 mg / tabletPO
Claritek 500 mg tablet
Getz Pharma (Pvt.) Limited
Tablet500 mg / tabletPO
Claritek suspension 125 mg/5 mL
Getz Pharma (Pvt.) Limited
Final reconstituted strength. Store below 30°C; use within 14 days at room temperature.
Oral Liquid125 mg / 5 mLPO
Claritek suspension 250 mg/5 mL
Getz Pharma (Pvt.) Limited
Final reconstituted strength. Store below 30°C; use within 14 days at room temperature.
Oral Liquid250 mg / 5 mLPO

Monitoring and Administration

Monitor fecal consistency and discontinue for severe diarrhea. Evaluate susceptibility and response.

For foal Rhodococcus treatment the described concurrent rifampin regimen is 10 mg/kg orally every 12 hours. Do not treat the clarithromycin dose as a complete stand-alone protocol.

Tablets may be dispersed in water for immediate administration; long-term compounded stability is not established.

For foal Rhodococcus treatment, another rifampin partner regimen is 5 mg/kg orally every 12 hours or 10 mg/kg every 24 hours. Do not merge partner doses from different protocols.

Keep reconstituted conventional oral suspension at room temperature and discard after 14 days; do not refrigerate that preparation.

Scroll to Top